📈 Daily US & Taiwan stock briefing: Python fetches real quotes (no hallucinated prices), writes a structured report, optional Notion sync.
Discover, backtest and validate US stock trading strategies, pick from any universe, and generate an IBKR paper-trading deployment script. No API keys, free daily data, institutional anti-overfit validation.
Institutional-grade fundamental research in English for US and Taiwan stocks — built on deterministic valuation engines and forensic accounting checks, not news aggregation. Dual-track DCF, earnings-quality audit, Beneish M-score, and a watchlist that is re-checked against the next earnings print. The only skill that reads Taiwan's Chinese-language primary sources (MOPS filings, monthly revenue, earnings calls) and delivers the analysis in English. Informational only — not investment advice.
Built on clinical epidemiology, biostatistics, causal inference, and evidence-based medicine. TrialReviewer analyzes RCTs, observational studies, meta-analyses, and diagnostic research using effect sizes, survival analysis, bias detection, GRADE, and benefit-harm frameworks to judge whether findings are valid, meaningful, and practice-changing.
Give it a date, a keyword, and an outlet — get every US story published that day, summarised and sourced. Covers 22 vetted American outlets, from Reuters and AP to the New York Times, Wall Street Journal, Bloomberg, CNBC, CNN, Fox News and Politico. Web articles only. Every item gets an original headline, a 3-10 sentence summary, the outlet’s own excerpt and a direct link. The window is fixed to 00:00-23:59 Eastern Time and printed on every brief, so you always know exactly what was counted.
Type any US ticker for a 30-second read: valuation vs its own history, growth, quality, technical structure, earnings catalyst, plus a 12-month momentum rank and a daily market dashboard. A reading engine — not investment advice.